← Feed

$ADPT

2 theses
bullish 0%neutral 0%bearish 100%
Avg return (1y)
—
Win rate (1y)
— (0 resolved)
1d3d1w1m3m6m1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$ADPTSEC Form 4bearish
ROBINS CHAD M · CEO and Chairman at Adaptive Biotechnologies Corp · 5h agono track record yet
Sold 600,000 @ $24.80 avg · $14,882,166 · 2026-08-17

Form 4: ROBINS CHAD M sold ADPT

ROBINS CHAD M (CEO and Chairman at Adaptive Biotechnologies Corp) reported an open-market sale of 600,000 shares of ADPT at an average $24.80, roughly $14,882,166, in a Form 4 filed 2026-08-19.

View filing on SEC.gov →
$ADPTSEC Form 4bearish
NEUPERT PETER M · Adaptive Biotechnologies Corp · 5h agono track record yet
Sold 124,690 @ $25.15 avg · $3,135,850 · 2026-08-17

Form 4: NEUPERT PETER M sold ADPT

NEUPERT PETER M (Director at Adaptive Biotechnologies Corp) reported an open-market sale of 124,690 shares of ADPT at an average $25.15, roughly $3,135,850, in a Form 4 filed 2026-08-19.

View filing on SEC.gov →

End of results.